日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm

Pivekimab Sunirine 治疗浆细胞样树突状细胞肿瘤

Pemmaraju, Naveen; Marconi, Giovanni; Montesinos, Pau; Lane, Andrew A; Mazzarella, Luca; Sallman, David A; Ulrickson, Matthew L; Schiller, Gary J; Erba, Harry P; Wang, Eunice S; Walter, Roland B; Deconinck, Eric; Aribi, Ahmed; Legrand, Ollivier; Lebon, Delphine; Maisano, Valerio; Martinelli, Giovanni; DeAngelo, Daniel J; Derenzini, Enrico; Du, Yining; Lakshmikanthan, Sribalaji; Potluri, Jalaja; Kantarjian, Hagop M; Daver, Naval G

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML

BRG1/BRM抑制剂联合BET抑制剂或地西他滨治疗高危MECOM重排急性髓系白血病疗效显著。

Fiskus, Warren; Mill, Christopher P; Piel, Jessica; Collins, Mike; Hentemann, Murphy; Cuglievan, Branko; Birdwell, Christine E; Das, Kaberi; Davis, John A; Hou, Hanxi; Jain, Antrix; Malovannaya, Anna; Flores, Lauren B; Kadia, Tapan M; Daver, Naval; Sasaki, Koji; Takahashi, Koichi; Hammond, Danielle; Wang, Jian; Loghavi, Sanam; Su, Xiaoping; DiNardo, Courtney D; Delwel, Ruud; Bhalla, Kapil N

Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies

维奈托克治疗相关非核心结合因子急性髓系白血病的疗效

Senapati, Jayastu; Croden, Jennifer; Garcia-Manero, Guillermo; Takahashi, Koichi; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Short, Nicholas James; Jabbour, Elias; Haddad, Fadi; Marvin-Peek, Jennifer; Abbas, Hussein A; Bose, Prithviraj; Tang, Guilin; Loghavi, Sanam; Shpall, Elizabeth J; Ramdial, Jeremy; Popat, Uday R; Champlin, Richard E; Ravandi, Farhad; Kantarjian, Hagop M; Dinardo, Courtney D

BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML

基于BET抑制剂的联合疗法靶向MECOM重排(r) AML中的新型依赖性

Birdwell, Christine E; Fiskus, Warren; Mill, Christopher P; Kadia, Tapan M; Daver, Naval; DiNardo, Courtney D; Sasaki, Koji; Davis, John A; Das, Kaberi; Hou, Hanxi; Jain, Antrix; Malovannaya, Anna; Flores, Lauren B; Pourebrahim, Rasoul; Yuan, Selina; Su, Xiaoping; Ceribelli, Michele; Bhalla, Kapil N

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes

异基因造血干细胞移植对高危骨髓增生异常综合征患者的影响

Bazinet, Alexandre; Bataller, Alex; Chien, Kelly; Sasaki, Koji; Montalban-Bravo, Guillermo; Hammond, Danielle; Bouligny, Ian; Swaminathan, Mahesh; Jen, Wei Ying; Kugler, Eitan; Kanagal-Shamanna, Rashmi; Kadia, Tapan; Borthakur, Gautam; DiNardo, Courtney; Short, Nicholas; Pemmaraju, Naveen; Jabbour, Elias; Daver, Naval; Ravandi, Farhad; Urrutia, Samuel; Gener-Ricos, Georgina; Braish, Julie; Briski, Robert; Rodriguez-Sevilla, Juan Jose; Li, Ziyi; Champlin, Richard E; Shpall, Elizabeth J; Alousi, Amin; Oran, Betul; Hosing, Chitra; Ramdial, Jeremy L; Olson, Amanda; Pierce, Sherry; Chen, Julianne; Kantarjian, Hagop; Garcia-Manero, Guillermo; Popat, Uday

Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor

一线去甲基化药物维奈托克联合FLT3抑制剂治疗FLT3突变型急性髓系白血病患者的长期疗效

Short, Nicholas J; Loghavi, Sanam; Yilmaz, Musa; Karrar, Omer; Kim, Kunhwa; Dinardo, Courtney D; Kadia, Tapan M; Maroun, Manuel; Borthakur, Gautam; Issa, Ghayas C; Jabbour, Joseph; Oran, Betul; Shpall, Elizabeth J; Popat, Uday; Patel, Keyur P; Routbort, Mark; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop; Daver, Naval

A phase I, single-arm, open-label, dose-escalation, multicenter study of SAR445419, an off-the-shelf, ex vivo expanded allogeneic natural killer cell product, in participants with relapsed or refractory acute myeloid leukemia

一项针对复发或难治性急性髓系白血病患者的 I 期、单臂、开放标签、剂量递增、多中心研究,旨在评估 SAR445419(一种现成的、体外扩增的异基因自然杀伤细胞产品)的疗效。

Konopleva, Marina; Bhatt, Vijaya Raj; Mantzaris, Ioannis; Maiti, Abhishek; Gundabolu, Krishna; Schafer, Jolie; Jensen, Kyle; Saleem, Rao; Li, Yi; Drewniak, Agata; Bay, Pierre; Huh, Winston; Yildirim, Ozlem; Abbadessa, Giovanni; Cooley, Sarah; Daver, Naval

Acute myeloid leukemia management and research in 2025

2025年急性髓系白血病管理和研究

Kantarjian, Hagop M; DiNardo, Courtney D; Kadia, Tapan M; Daver, Naval G; Altman, Jessica K; Stein, Eytan M; Jabbour, Elias; Schiffer, Charles A; Lang, Amy; Ravandi, Farhad

Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML

对于不适合接受强化化疗的异柠檬酸脱氢酶突变型急性髓系白血病患者,一线三联疗法(包括去甲基化药物、维奈托克和异柠檬酸脱氢酶抑制剂)的疗效

DiNardo, Courtney D; Marvin-Peek, Jennifer; Loghavi, Sanam; Takahashi, Koichi; Issa, Ghayas C; Jen, Wei-Ying; Daver, Naval G; Reville, Patrick K; Short, Nicholas J; Sasaki, Koji; Mullin, Jillian K; Bradley, Corey A; Borthakur, Gautam; Maiti, Abhishek; Alvarado, Yesid; Pemmaraju, Naveen; Abbas, Hussein A; Hammond, Danielle E; Haddad, Fadi; Bravo, Guillermo Montalban; Chien, Kelly S; Yilmaz, Musa; Kornblau, Steven M; Jabbour, Elias; Ravandi, Farhad; Kadia, Tapan; Garcia-Manero, Guillermo; Konopleva, Marina Y; Kantarjian, Hagop M

A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias

DS-1594 menin抑制剂治疗复发/难治性急性白血病的1/2期研究

Senapati, Jayastu; Konopleva, Marina; Issa, Ghayas C; Jabbour, Elias; Kadia, Tapan; DiNardo, Courtney; Borthakur, Gautam; Pemmaraju, Naveen; Short, Nicholas J; Yilmaz, Musa; Deshmukh, Indraneel; Alvarez, Joie; Loghavi, Sanam; Tang, Guilin; Abbas, Hussein A; Andreeff, Michael; Bhalla, Kapil; Midde, Narasimha M; Said, Nabil; Noyalis, Amy; Mires, Derek E; Ning, Jing; Xiao, Lianchun; Ravandi, Farhad; Garcia-Manero, Guillermo; Kantarjian, Hagop M; Daver, Naval G